Last week we saw sale of promoter’s stake in Ranbaxy, India’s largest generic pharma company, to Dii Ichi Sankyo of Japan. Ranbaxy, set up in 1961, was valued at $ 8.5 b. in the deal. During a prior week I had attended the analyst meet of Punjab National Bank, which, after 119 years, has grown to become the largest but one (after SBI) public sector bank.